194 related articles for article (PubMed ID: 27314542)
1. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers predict brain tumor presence and response to therapy.
Smith ER; Zurakowski D; Saad A; Scott RM; Moses MA
Clin Cancer Res; 2008 Apr; 14(8):2378-86. PubMed ID: 18413828
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies.
Marler JJ; Fishman SJ; Kilroy SM; Fang J; Upton J; Mulliken JB; Burrows PE; Zurakowski D; Folkman J; Moses MA
Pediatrics; 2005 Jul; 116(1):38-45. PubMed ID: 15995028
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
[TBL] [Abstract][Full Text] [Related]
5. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume.
Bookland M; Tang-Schomer M; Gillan E; Kolmakova A
Acta Neurochir (Wien); 2018 Aug; 160(8):1571-1581. PubMed ID: 29911246
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
[TBL] [Abstract][Full Text] [Related]
7. [Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas].
Dosquet C; Coudert MC; Wassef M; Enjolras O; Drouet L
Ann Dermatol Venereol; 1998 May; 125(5):313-6. PubMed ID: 9747277
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
9. Urine vascular biomarkers in Sturge-Weber syndrome.
Sreenivasan AK; Bachur CD; Lanier KE; Curatolo AS; Connors SM; Moses MA; Comi AM
Vasc Med; 2013 Jun; 18(3):122-8. PubMed ID: 23720035
[TBL] [Abstract][Full Text] [Related]
10. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells.
Hakki SS; Hakki EE; Nohutcu RM
J Periodontal Res; 2009 Dec; 44(6):794-802. PubMed ID: 19602122
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib is effective against juvenile pilocytic astrocytoma in vitro.
Foreman NK; Gore L; Wells D; Straessle J; Heideman R; Donson AM
Pediatr Blood Cancer; 2006 Sep; 47(3):293-8. PubMed ID: 16206208
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
Lin RY; Argenta PA; Sullivan KM; Adzick NS
Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in children with brain tumors.
Sobol-Milejska G; Mizia-Malarz A; Musiol K; Chudek J; Bożentowicz-Wikarek M; Wos H; Mandera M
Adv Clin Exp Med; 2017 Jul; 26(4):571-575. PubMed ID: 28691414
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of primarily metastatic juvenile pilocytic astrocytoma in children.
Yecies D; Fisher PG; Cheshier S; Edwards M; Grant G
J Neurosurg Pediatr; 2018 Jan; 21(1):49-53. PubMed ID: 29125440
[TBL] [Abstract][Full Text] [Related]
15. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
16. [Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation].
Zhang L; Lin XX; Qi ZL; Dong JS; Zou LJ; Dai CC; Li W; Wang W
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):186-8. PubMed ID: 16635349
[TBL] [Abstract][Full Text] [Related]
17. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas.
Bian XW; Du LL; Shi JQ; Cheng YS; Liu FX
Anal Quant Cytol Histol; 2000 Jun; 22(3):267-74. PubMed ID: 10872046
[TBL] [Abstract][Full Text] [Related]
18. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.
Jacob K; Albrecht S; Sollier C; Faury D; Sader E; Montpetit A; Serre D; Hauser P; Garami M; Bognar L; Hanzely Z; Montes JL; Atkinson J; Farmer JP; Bouffet E; Hawkins C; Tabori U; Jabado N
Br J Cancer; 2009 Aug; 101(4):722-33. PubMed ID: 19603027
[TBL] [Abstract][Full Text] [Related]
19. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.
Allen DK; Waters DJ; Knapp DW; Kuczek T
J Vet Intern Med; 1996; 10(4):231-4. PubMed ID: 8819047
[TBL] [Abstract][Full Text] [Related]
20. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Coticchia CM; Curatolo AS; Zurakowski D; Yang J; Daniels KE; Matulonis UA; Moses MA
Gynecol Oncol; 2011 Nov; 123(2):295-300. PubMed ID: 21889192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
